VILL

Across TCGA pan-cancer cohorts, VILL Mutation is linked to patient survival in 4 of 34 cancer types, making it a survival-associated VILL data layer compared with 26 for mass-spec protein and 6 for mass-spec protein.

The strongest signal is observed in uterine corpus endometrial carcinoma (UCEC), where higher VILL Mutation is associated with better overall survival. In most high-consensus cancer types, elevated VILL expression acts as an unfavorable survival marker, although some lineages such as UCEC and SKCM show a favorable association.

UCEC, ACC, and HNSC are the cancer types where VILL Mutation most reproducibly stratifies survival.

Mutation survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
UCEC	OS	Median	All	1.000	0.658	.016	24	view →
ACC	OS	Median	All	0.188	0.820	<.001	15	view →
HNSC	OS	Median	III,IV	0.139	0.656	.007	12	view →
SKCM	DFS	Median	II,III,IV	0.637	0.216	.021	4	view →

Pink = unfavorable, green = favorable. Showing the 4 strongest of 4 lineages.

VILL–UCEC (OS)

Open the UCEC breakdown →